PTHLH and hypercalcemia disease: Glucocorticoids are used for PTHrP postpartum hypercalcemia because they suppress 1,25(OH)2D production, increase vitamin D breakdown, reduce calcium absorption from the gut, decrease bone resorption, act quickly, and are suitable for short-term management postpartum.